07 Jan 2001

Floradix® Multipretten® (Floradix® Multipretten® Kräuter-Dragees) - Deutschland

Updated: 07 Jan 2001

Floradix® Multipretten® Kräuter-Dragees

Erhaltung einer gesunden Magenfunktion und Förderung der Eiweißverdauung. Zum Schutz gegen Gasbildung, Blähungen, Völlegefühl und Magendruck.

Floradix® Multipretten® Description, Presentation and Dosage

Floradix® Multipretten® Description

Floradix® Multipretten® Drug Class Description

Andere Kombinationen

Floradix® Multipretten® Drug Description

1 Drg. enth.: Extr. Fruct. Carvi (spir. sicc.) 20 mg, Extr. Fruct. Foeniculi (spir. sicc.) 20 mg, Ol. Anisi (spir. sicc.) 20 mg, Extr. Fruct. Coriandri (spir. sicc.) 10 mg, Extr. Herba Absinthii (spir. sicc.) 30 mg, Extr. Fol. Menthae pip. (spir. sicc.) 20 mg, Extr. Herba Millefolii (spir. sicc.) 20 mg, Extr. Rad. Imperatoriae (spir. sicc.) 10 mg, Ol. Anisi (DAB) 0,8 mg, Ol. Carvi (DAB) 0,8 mg, Ol. Foeniculi (DAB) 0,8 mg, Ol. Menthae pip. (DAB) 0,8 mg, Ol. Coriandri 0,4 mg, Bromelaine 8 mg, Enzymgemisch aus Aspergillus Oryzae 20 mg entspr. einem Pankreatin 4 mal NF XIII pro Drg. Mindestgehalt von 0,003 ml an ätherischem Öl mit 0,8 mg Trans-Anethol u. 0,3 mg Carvon.

Floradix® Multipretten® Generic Name

Floradix® Multipretten® Kräuter-Dragees

Floradix® Multipretten® Presentation

Floradix® Multipretten® Presentation

Floradix® Multipretten® Kräuter-Dragees

Floradix® Multipretten® Manufacturer

Salushaus

Related Learning Zones

Bedwetting Knowledge Centre and
Interactive Case Studies

Bedwetting Knowledge Centre and </br>Interactive Case Studies

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and interactive case studies: ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Floradix® Multipretten® Dosage

Floradix® Multipretten® Adult Dosage

Talkum, Arabisches Gummi, Calciumcarbonat (E 170), E 171, Weißer Ton, Macrogol.

Floradix® Multipretten® Precautions, Reactions and Contraindications

Floradix® Multipretten® Special Precautions

Floradix® Multipretten® Special Precautions

A 97

Floradix® Multipretten® Adverse Reactions

Floradix® Multipretten® Adverse Reactions

F 5 a

Related Drugs - Gastroenterology

Back to top